The sites acquired from Phoenix Mecano AG (SIX Swiss Exchange: PM) have been able to win some of the leading companies in Cicor's target market of medical technology as customers in recent years and expect revenues of more than EUR 30 million in the 2022 financial year. The EBITDA margin is expected to be at a level comparable to that of the Cicor Group. The German sites will be integrated into the organizational unit "Cicor Germany" of the Electronic Manufacturing Services (EMS) Division. The Tunisian site will also become part of the global production network of the EMS Division.
The acquisition will provide PMDE's customers with access to the extensive range of competencies in the areas of development, manufacturing and supply chain management, the global presence and synergies in material procurement. Cicor will benefit from PMDE's location in Tunisia, which is attractive due to its geographic proximity, availability of employees and competitive cost structures.
The closing of the transaction is expected to be completed within the next 2 - 4 months and is subject to customary closing conditions. The transaction will be financed by funds from the issued mandatory convertible bond (MCB).
The company's acquisition strategy will also be one of the main topics at this year's Cicor Capital Markets Event, which will take place on Monday, November 21, 2022 from 16:30 CET at the Widder Hotel in Zurich. For further information, please visit our website cicor.com/capitalmarketsevent.
Cicor Management AG Media & Investor Relations
Gebenloostrasse 15 Phone +41 71 913 73 00
CH-9552 Bronschhofen Email: email@example.com